Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

SULSTER

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

Standard Dose
EQ 0.23% PHOSPHATE;10%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SULSTER is listed in Drugs@FDA under application 074511 (ANDA).

Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.23% PHOSPHATE;10% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 1996-07-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview SULSTER is listed in Drugs@FDA under application 074511 (ANDA). Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.23% PHOSPHATE;10% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 1996-07-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.